Not only does the move stand to negatively impact the drug company's bottom line, GSK has broken new ground before in disclosures and remains an outlier.
GlaxoSmithKline, the largest drug company in Britain and one of the largest in the world, has made an industry first move.
Health impact assessments (HIAs) are behind an emerging idea that public transportation — or even a state park — can be part of a prescription for good health.
GSK admits to major fraud, risks in early births, Obamacare quietly working away and a strike against low-carb diets in our Daily Briefing.
Bioethicist Leigh Turner, recently under fire from a stem cell company he criticized for ethical problems, talks about his research on medical tourism.
I wrote a piece recently for Health News Review about conflicts of interest. The original post is below, followed by more great examples of writers describing unexpected conflicts in detail.
The Drug Industry Document Archive have has some incredible documents on the antidepressant Paxil that provide windows into a previously closed-off world.
"We're homogenizing the way the world goes mad," Ethan Watters, author of "Crazy Like Us," today told USC/California Endowment National Health Journalism Fellows gathered in Los Angeles this week.
